Bortezomib will enhance the degree or influence of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. Amplified flibanserin adverse effects may well happen if coadministered with multiple weak CYP3A4 inhibitors. Critical: The drug information on this web site is supposed to become academic. It is not a substitute for https://georgeq888dpz1.wikistatement.com/user